div > div.group > p:first-child"> Biogen — Biogen shares are tumbling after the drugmaker and Japanese partner Eisai discontinued late-stage trials of an Alzheimer's treatment. That came after an independent data monitoring committee said the treatment was unlikely to meet its primary goal.
Lands' End — The apparel retailer reported adjusted quarterly profit of 50 cents per share, above the 41 cents a share consensus estimate. Revenue also beat Wall Street forecasts. Comparable-store sales rose 9.1 percent, compared to a Refinitiv consensus estimate of a 2.0 percent increase. Micron Technology — Micron reported adjusted quarterly profit of $1.71 per share, 4 cents a share above estimates. The chipmaker's revenue also topped Street forecasts. Micron's revenue forecast for the current quarter was below estimates, however, and the company is also trimming its capital expenditures as well as idling some production lines amid what it calls a challenging market environment.
Guess — Guess missed estimates by 5 cents a share with adjusted quarterly profit of 70 cents per share, though the apparel maker's revenue beat forecasts. Guess gave a weaker-than-expected forecast for the current quarter and full year.
Average working class people should NEVER buy stocks. It's Gambling. The only people who make money in it are insiders and millionaires and billionaires.
mr_jettlife
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: MarketWatch - 🏆 3. / 97 Lire la suite »
La source: MarketWatch - 🏆 3. / 97 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: Reuters - 🏆 2. / 97 Lire la suite »